Vicarious Surgical announces plan to pursue Nasdaq listing

Vicarious Surgical (RBOT) announced a series of strategic actions to support a potential relisting of its common stock on a national exchange. The company said, “Over the past several months, Vicarious Surgical has implemented significant operational and cost discipline initiatives designed to align the Company’s expense structure with its current stage of development while maintaining progress toward key technology milestones. As a result of these initiatives, the Company expects full-year 2026 cash burn of approximately $19 million, a substantial reduction from the approximately $35 million burn guidance provided in late 2025. In mid-2025, the Company’s annual cash burn was approximately $50 million due to its operating structure. These changes reflect a significant structural improvement in the Company’s cost profile, including increased use of outsourcing and operational efficiencies, while preserving progress toward key development milestones. The Company’s strategic cost discipline has not slowed momentum in the development of the Vicarious Surgical System. Vicarious Surgical remains on track to achieve system design freeze by the end of 2026, a critical milestone in the Company’s regulatory and commercialization roadmap. Based on its current operating plan, the Company believes that its existing cash resources provide runway through the second quarter of 2026, allowing the Company to pursue its capital markets strategy.”